596820-22-3 Usage
Uses
Used in Pharmaceutical Industry:
2,4-Dioxa-7-aza-3-phosphaoctan-8-oic acid, 6-[2-(4-octylphenyl)ethyl]-1-phenyl-3-(phenylmethoxy)-, phenylmethyl ester, 3-oxide is used as a potential pharmaceutical agent for its unique chemical structure and potential reactivity. The presence of heteroatoms, aromatic rings, and the esterified phenylmethyl group may contribute to its biological activity, making it a candidate for the development of new drugs with specific therapeutic effects.
Used in Drug Delivery Systems:
2,4-Dioxa-7-aza-3-phosphaoctan-8-oic acid,
6-[2-(4-octylphenyl)ethyl]-1-phenyl-3-(phenylmethoxy)-, phenylmethyl
ester, 3-oxide's unique structure and potential reactivity may also make it suitable for use in drug delivery systems. It could be employed as a carrier or component in the design of novel drug delivery systems, aiming to improve the delivery, bioavailability, and therapeutic outcomes of various pharmaceutical agents.
Used in Chemical Research:
2,4-Dioxa-7-aza-3-phosphaoctan-8-oic acid, 6-[2-(4-octylphenyl)ethyl]-1-phenyl-3-(phenylmethoxy)-, phenylmethyl ester, 3-oxide can also be used in chemical research to explore its reactivity, stability, and potential interactions with other molecules. This research could lead to a better understanding of its properties and applications, as well as the development of new synthetic methods or modifications to its structure for improved performance in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 596820-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,6,8,2 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 596820-22:
(8*5)+(7*9)+(6*6)+(5*8)+(4*2)+(3*0)+(2*2)+(1*2)=193
193 % 10 = 3
So 596820-22-3 is a valid CAS Registry Number.
596820-22-3Relevant articles and documents
Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720
Hale, Jeffrey J.,Neway, William,Mills, Sander G.,Hajdu, Richard,Ann Keohane, Carol,Rosenbach, Mark,Milligan, James,Shei, Gan-Ju,Chrebet, Gary,Bergstrom, James,Card, Deborah,Koo, Gloria C.,Koprak, Sam L.,Jackson, Jesse J.,Rosen, Hugh,Mandala, Suzanne
, p. 3351 - 3355 (2007/10/03)
Alteration in lymphocyte trafficking and prevention of graft rejection in rodents observed on exposure to FTY720 (1) or its corresponding phosphate ester 2 can be induced by the systemic administration of potent sphingosine-1- phosphate receptor agonists
